Area of research
Hematology · Oncology
Research interest
Research interests include Multiple Myeloma Research and Treatments, Cancer Treatment and Pharmacology, Chronic Lymphocytic Leukemia Research, and Protein Degradation and Inhibitors.
Efficacy and safety of oral panobinostat plus subcutaneous bortezomib and oral dexamethasone in patients with relapsed or relapsed and refractory multiple myeloma (PANORAMA 3): an open-label, randomised, phase 2 study
Daratumumab plus Bortezomib, Melphalan, and Prednisone for Untreated Myeloma
Panobinostat plus bortezomib and dexamethasone versus placebo plus bortezomib and dexamethasone in patients with relapsed or relapsed and refractory multiple myeloma: a multicentre, randomised, double-blind phase 3 trial